• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Causes of late mortality in pediatric liver transplant recipients.儿童肝移植受者晚期死亡的原因。
Ann Surg. 1998 Feb;227(2):289-95. doi: 10.1097/00000658-199802000-00020.
2
Pediatric liver transplantation. A single center experience spanning 20 years.小儿肝移植。一个中心20年的经验。
Transplantation. 2002 Mar 27;73(6):941-7. doi: 10.1097/00007890-200203270-00020.
3
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus.接受他克莫司治疗的小儿初次肝移植术后1年以上的死亡原因
Transplantation. 2002 Dec 27;74(12):1721-4. doi: 10.1097/00007890-200212270-00014.
4
Long-term survival and late graft loss in pediatric liver transplant recipients--a 15-year single-center experience.小儿肝移植受者的长期生存及晚期移植物丢失——单中心15年经验
Liver Transpl. 2002 Jul;8(7):615-22. doi: 10.1053/jlts.2002.34149.
5
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.关于在他克莫司免疫抑制下进行的原位肝移植,我们了解到了什么?对首批1000例患者的长期随访。
Ann Surg. 1999 Sep;230(3):441-8; discussion 448-9. doi: 10.1097/00000658-199909000-00016.
6
Long-term survival after liver transplantation.肝移植后的长期生存
J Pediatr Surg. 1999 May;34(5):845-9; discussion 849-50. doi: 10.1016/s0022-3468(99)90385-8.
7
Long-term outcomes and predictors in pediatric liver retransplantation.儿童肝脏再次移植的长期结局及预测因素
Pediatr Transplant. 2015 Dec;19(8):866-74. doi: 10.1111/petr.12588. Epub 2015 Sep 12.
8
Analysis of causes of death in liver transplant recipients who survived more than 3 years.对存活超过3年的肝移植受者的死因分析。
Liver Transpl. 2001 Sep;7(9):811-5. doi: 10.1053/jlts.2001.27084.
9
Late mortality after orthotopic liver transplantation.
Am J Surg. 2001 May;181(5):475-9. doi: 10.1016/s0002-9610(01)00595-5.
10
One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future.132例连续无医院死亡的小儿肝移植:经验教训与未来展望。
Ann Surg. 2004 Dec;240(6):1002-12; discussion 1012. doi: 10.1097/01.sla.0000146148.01586.72.

引用本文的文献

1
Recipient Age Predicts 20-Year Survival in Pediatric Liver Transplant.受者年龄预测小儿肝移植 20 年生存率。
Can J Gastroenterol Hepatol. 2022 Sep 17;2022:1466602. doi: 10.1155/2022/1466602. eCollection 2022.
2
Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening.抗菌药物管理与筛查时代儿科肝移植患者多重耐药菌的流行病学、危险因素及转归
Antibiotics (Basel). 2022 Mar 15;11(3):387. doi: 10.3390/antibiotics11030387.
3
Multidrug-resistant organisms: A significant cause of severe sepsis in pediatric intestinal and multi-visceral transplantation.多重耐药菌:小儿肠和多脏器移植术后严重脓毒症的重要原因。
Am J Transplant. 2022 Jan;22(1):122-129. doi: 10.1111/ajt.16756. Epub 2021 Jul 28.
4
TRANSITION of Pediatric Liver Transplant Patients to Adult Care: a Review.儿科肝移植患者过渡至成人照护:综述。
Curr Gastroenterol Rep. 2021 Jan 29;23(3):3. doi: 10.1007/s11894-020-00802-1.
5
Severe Sepsis in Pediatric Liver Transplant Patients: The Emergence of Multidrug-Resistant Organisms.儿科肝移植患者的严重脓毒症:多药耐药菌的出现。
Pediatr Crit Care Med. 2019 Jul;20(7):e326-e332. doi: 10.1097/PCC.0000000000001983.
6
Development and content validation of measures assessing adherence barriers and behaviors for use in clinical care.评估用于临床护理的依从性障碍和行为的措施的制定和内容验证。
Res Social Adm Pharm. 2019 Sep;15(9):1168-1176. doi: 10.1016/j.sapharm.2018.10.001. Epub 2018 Oct 5.
7
Transition after pediatric liver transplantation - Perceptions of adults, adolescents and parents.小儿肝移植后的转变——成人、青少年及家长的看法
World J Gastroenterol. 2017 Apr 7;23(13):2365-2375. doi: 10.3748/wjg.v23.i13.2365.
8
Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children.利用基于细胞的检测方法预测细胞排斥反应:儿童的临床前评估
Transplantation. 2017 Jan;101(1):131-140. doi: 10.1097/TP.0000000000001076.
9
Assessing allocation of responsibility for health management in pediatric liver transplant recipients.评估小儿肝移植受者健康管理责任的分配情况。
Pediatr Transplant. 2015 Aug;19(5):538-46. doi: 10.1111/petr.12466. Epub 2015 Mar 31.
10
Post-transplant adjustment--the later years.移植后的调整——晚年时期
Pediatr Transplant. 2014 Nov;18(7):675-88. doi: 10.1111/petr.12366. Epub 2014 Sep 13.

本文引用的文献

1
Actual causes of death in the United States.美国的实际死因。
JAMA. 1993 Nov 10;270(18):2207-12.
2
Liver transplantation in small babies.小婴儿的肝移植
J Pediatr Surg. 1993 Aug;28(8):1051-3. doi: 10.1016/0022-3468(93)90517-o.
3
Is age less than 1 year a high-risk category for orthotopic liver transplantation?年龄小于1岁是原位肝移植的高风险类别吗?
J Pediatr Surg. 1993 Aug;28(8):1048-50. doi: 10.1016/0022-3468(93)90516-n.
4
An analysis of liver transplant experience from 37 transplant centers as reported to Medicare.对向医疗保险机构报告的37个移植中心的肝移植经验进行的分析。
Transplantation. 1993 Sep;56(3):554-61. doi: 10.1097/00007890-199309000-00012.
5
De novo malignancy in pediatric organ transplant recipients.
J Pediatr Surg. 1994 Feb;29(2):221-6; discussion 227-8. doi: 10.1016/0022-3468(94)90322-0.
6
Infants are a higher intraoperative risk group for orthotopic liver transplantation.婴儿是原位肝移植术中风险较高的群体。
Transplant Proc. 1994 Feb;26(1):196-7.
7
Development of indications and results during 10 years of orthotopic liver transplantation.原位肝移植10年期间适应证的发展及结果
Clin Transpl. 1993:153-60.
8
Recent advances in hepatic transplantation at the University of Pittsburgh.匹兹堡大学肝脏移植的最新进展。
Clin Transpl. 1993:137-52.
9
Complications of splenectomy. Etiology, prevention, and management.脾切除术的并发症。病因、预防及处理
Surg Clin North Am. 1983 Dec;63(6):1313-30. doi: 10.1016/s0039-6109(16)43191-9.
10
Stratifying the causes of death in liver transplant recipients. An approach to improving survival.
Arch Surg. 1989 Aug;124(8):895-900. doi: 10.1001/archsurg.1989.01410080025003.

儿童肝移植受者晚期死亡的原因。

Causes of late mortality in pediatric liver transplant recipients.

作者信息

Sudan D L, Shaw B W, Langnas A N

机构信息

Department of Surgery, University of Nebraska Medical Center, Omaha, USA.

出版信息

Ann Surg. 1998 Feb;227(2):289-95. doi: 10.1097/00000658-199802000-00020.

DOI:10.1097/00000658-199802000-00020
PMID:9488529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1191248/
Abstract

OBJECTIVE

This study was undertaken to review the incidence and causes of death in children who have survived long-term (more than 1 year) after liver transplantation (LT).

SUMMARY BACKGROUND DATA

No studies of the causes of late mortality in pediatric LT recipients are currently available in the literature.

METHODS

The study group consists of 212 pediatric patients who survived more than 1 year after LT. Twenty-three of these patients subsequently died (mean follow-up = 5.3 yr). Hospital records, office charts, and autopsy records were reviewed retrospectively to identify the causes of death. The patients who died were further evaluated by age, gender, length of survival, primary diagnosis, immunosuppression, and retransplantation.

RESULTS

The most common cause of death was graft failure, followed closely by infection. In patients dying from graft failure, eight of the nine patients underwent retransplantation and no child survived more than three liver transplants. Overwhelming infections occurred suddenly in eight children who had been previously healthy. Noncompliance was the third most common cause of death, primarily in older children. One child died from a posttransplant lymphoproliferative disorder (PTLD). Actuarial survival at 10 years is 83.7% (based on 100% survival at 1 year). There was no difference in survival based on primary disease. Retransplantation was far more prevalent in the nonsurvivors (47.8%) compared with survivors (13.7%) (p < 0.05). There were no significant differences in survival based on age, gender, or immunosuppression.

CONCLUSIONS

Late mortality in children continues to be directly related to complications of LT and immunosuppression, even after the first year of transplantation. This is in contrast to adult liver transplant recipients, where approximately 50% of late deaths were related to LT and the remainder were because of unrelated illnesses.

摘要

目的

本研究旨在回顾肝移植(LT)术后长期存活(超过1年)儿童的死亡发生率及原因。

总结背景数据

目前文献中尚无关于小儿肝移植受者晚期死亡原因的研究。

方法

研究组由212例肝移植术后存活超过1年的儿科患者组成。其中23例患者随后死亡(平均随访时间=5.3年)。回顾性分析医院记录、门诊病历和尸检记录以确定死亡原因。对死亡患者进一步按年龄、性别、存活时间、初始诊断、免疫抑制情况和再次移植情况进行评估。

结果

最常见的死亡原因是移植物衰竭,其次是感染。在因移植物衰竭死亡的患者中,9例中有8例接受了再次移植,且没有儿童能存活超过三次肝移植。8名此前健康的儿童突然发生严重感染。不依从是第三常见的死亡原因,主要发生在年龄较大的儿童中。1名儿童死于移植后淋巴细胞增生性疾病(PTLD)。10年实际生存率为83.7%(基于1年时100%的生存率)。基于初始疾病的生存率无差异。与存活者(13.7%)相比,再次移植在非存活者中更为普遍(47.8%)(p<0.05)。基于年龄、性别或免疫抑制情况的生存率无显著差异。

结论

即使在肝移植术后第一年之后,儿童的晚期死亡仍然与肝移植及免疫抑制的并发症直接相关。这与成人肝移植受者不同,成人肝移植受者中约50%的晚期死亡与肝移植相关,其余则是由于无关疾病。